Status:
COMPLETED
Comparison of Chemical Peeling Agent With Transamine for Treatment of Melasma
Lead Sponsor:
Combined Military Hospital Abbottabad
Conditions:
Melasma
Eligibility:
All Genders
20-50 years
Phase:
PHASE1
Brief Summary
Melasma is an acquired skin disorder characterized by hyper-melanosis. Melasma is a term that originates from the Greek root "melas" (black color) and was formerly known as chloasma. Melasma is more c...
Detailed Description
A randomized controlled trial study (single-blind) was done In the Dermatology Unit of the CMH, Abbottabad from June to November 2021 after Ethical Review Board approval, the 54 patients aged 20-50 ye...
Eligibility Criteria
Inclusion
- patients suffering from Melasma who attended the Dermatology department
Exclusion
- history of hormone therapy and contraceptive pills (within the previous 12 months)
- bleeding problems or concurrent use of anticoagulants
- Topical treatment such as hydroquinone (one month prior to the research)
- Active herpes simplex, face warts or active dermatoses
- History of hypersensitivity to some of the study's components
- Pregnant or lactating females
- Patients with unrealistic expectations
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2021
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT05362500
Start Date
June 1 2021
End Date
November 30 2021
Last Update
May 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Combined military hospital
Abbottābād, Kpk, Pakistan